- Zimbabwe Targets 70-Year Life Expectancy in Ambitious New Health Strategy
- Blood Group O in Zimbabwe: Why Hospitals Can Never Have Enough
- Vaccine Storage Temperature Guidelines: What Health Facilities Must Know
- Trump Signs Historic US$5.88 Billion Package to Expand HIV Funding
- African Heads of State Commit to Advance Local Manufacturing of Health Products
Swedish Embassy gives PSZ US$5 million grant
By Kuda Pembere At a time when access to sexual and reproductive health (SRH) services remains a challenge for many adolescent girls and young women in Zimbabwe, the Swedish Embassy in Harare has awarded a US$5 million grant to Population Services Zimbabwe (PSZ) to help improve access. Speaking during the grant signing ceremony, Sweden’s Ambassador
Read MorePSZ Reopens Upgraded Mbare Clinic
By Kuda Pembere Population Services Zimbabwe (PSZ) has reopened its clinic in Mbare following a major renovation exercise aimed at improving access to quality healthcare in the high-density suburb. Established in 2007, the clinic has served thousands of Mbare residents over the years. Officiating at the relaunch on Monday, Deputy Minister of Health and Child
Read MoreJoe Biden diagnosed with ‘aggressive form’ of prostate cancer
Former US president’s office said the cancer cells had spread to the bone and Biden, 82, was reviewing treatment options with doctors Former US President Joe Biden has been diagnosed with an “aggressive form” of prostate cancer that has metastasised to the bone, and he and his family are reviewing treatment options with doctors, his
Read MoreAfrica CDC and Unitaid partner to strengthen equitable access to health products in Africa
By Staff Reporter The Africa Centres for Disease Control and Prevention (Africa CDC) and Unitaid have formed a new strategic partnership to expand the production of essential health products in Africa and improve sustainable access to medicines, diagnostics, and medical oxygen across the continent. Signed on the margins of the 78th World Health Assembly, the Memorandum
Read MoreDr. Nyaradzo Mgodi Honored for Leadership in Landmark HIV Vaccine Study
By Michael Gwarisa Dr. Nyaradzo Mgodi, a renowned Zimbabwean clinician-researcher and the Site Leader for the University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) in Zengeza, has been awarded the prestigious HIV Vaccine Trials Network (HVTN) Service Award for her outstanding leadership and contribution to the groundbreaking Antibody Mediated Prevention (AMP) study. The award was
Read More